SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-19-011120
Filing Date
2019-08-22
Accepted
2019-08-22 16:38:28
Documents
4
Period of Report
2019-08-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fcsc82219form8-k.htm 8-K 48438
2 EXHIBIT 10.1 exhibit101employmentagreem.htm EX-10.1 96918
3 EXHIBIT 10.2 exhibit102employmentagreem.htm EX-10.2 98495
4 image0a40.jpg GRAPHIC 74382
  Complete submission text file 0001628280-19-011120.txt   345376
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000
Fibrocell Science, Inc. (Filer) CIK: 0000357097 (see all company filings)

IRS No.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31564 | Film No.: 191046460
SIC: 2834 Pharmaceutical Preparations